Summit Performance Psychiatry
Neuro-optimization for the data-driven mind
A concierge practice near Union Square treating cognitive performance as a measurable outcome, pairing IV ketamine with quantitative EEG-guided TMS.
Meets the full standard
7/7
criteria met
Board-certified medical director with psychiatric expertise
Someone who understands mood disorders as well as dosing — not an anesthesiologist moonlighting on weekends.
Comprehensive screening protocol
Cardiac, psychiatric, substance and medication history reviewed before anyone is accepted.
Integration support
Therapy, coaching or structured reflection built into the protocol — not sold as an optional add-on.
Transparent pricing
Full protocol cost quoted upfront, including consultation and maintenance assumptions.
Session environment
Calm, private, dignified. Sound, light and staffing designed with intent.
Outcome tracking
Validated measures taken before, during and after the protocol.
Personalized protocols
Dose, spacing and endpoints set against your goals — recovery, recalibration, or both.
Assessed by our editors from clinic interviews and published materials. Unmet criteria are not a verdict on care quality — they are what we could not confirm.
Meridian was founded by a psychiatrist and a neuroengineer who met at a UCSF neurostimulation lab. Their shared premise: mental health interventions should be as instrumented as the rest of a quantified life.
Every patient starts with a qEEG baseline and a ninety-minute performance intake covering sleep architecture, workload, and cognitive goals. TMS protocols are adjusted against the qEEG at defined checkpoints, and IV ketamine sessions include pre- and post-treatment cognitive batteries so progress is tracked on data, not just mood scales.
The practice is self-pay only and keeps a deliberately small caseload. Evening and early-morning slots exist for patients who cannot step away mid-day.
TMS is FDA-cleared for major depressive disorder and OCD. Some clinics offer it off-label for cognitive performance; evidence for this is Tier C. Esketamine (Spravato) is FDA-approved for treatment-resistant depression; generic ketamine is FDA-approved only as an anesthetic and is used off-label for mood. Use for cognitive performance or burnout is off-label; evidence for this is Tier C. Neurofeedback devices are not FDA-cleared for cognitive enhancement; evidence for performance use is Tier C.
This listing describes an optimization service. NeuroEdge.Health is a directory, not a medical referral service, and does not present any clinic as a treatment for a medical condition. If you are seeking care for depression, OCD or another condition, that is a medical decision — see seeking treatment for a condition and consult a physician.
Not sure if this is the right fit?
Answer six short questions and we'll suggest the clinics that match your city, treatment interest and budget.
Get matched